RNU7-193P

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, RNU7-193P RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated RNU7-193P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RNU7-193P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU7-193P expression acts as an unfavorable survival marker, although some lineages such as PAAD and CHOL show a favorable association.

KIRC, KICH, and ACC are the cancer types where RNU7-193P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
KIRCOSTertileAll0.4740.665<.001132view →
KICHDFSTertileAll0.0250.904<.001108view →
ACCDFSTertileII,III,IV0.2180.662<.00193view →
READDFSTertileAll0.1650.558.00551view →
KIRPDFSTertileII,III,IV0.0400.765<.00136view →
PAADOSTertileII,III,IV0.8650.394.01724view →
UCECDFSTertileIV0.2510.722.00618view →
THCADFSTertileAll0.7980.914.01212view →
CHOLDFSTertileAll0.8370.343.0489view →
HNSCDFSTertileAll0.2240.331.0299view →
Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

RNU7-193P–KIRC (OS)

Kaplan–Meier survival curve for RNU7-193P RNA-high vs -low samples in KIRC.

Open the KIRC breakdown →

Exploration